On the basis of recent evidence, visuo-spatial memory impairments seem to be the most constantly reported cognitive deficit in PD patients. [1] [2] [3] [4] DA lesions, obtained through either medial forebrain bundle or dorsal striatum 6-hyroxydopamine (6-OHDA) administrations, have been found to impair memory in the spatial version of the Morris water maze (MWM) in rodents. 5, 6) The ERM family consists of three closely related proteins, ezrin, radixin, and moesin (ERM proteins). 7) These proteins have a 4.1, ezrin, radixin, moesin (FERM) domain at the Nterminal region, which is involved in the linkage with transmembrane proteins. The C-terminal region of ERM proteins can interact with the N-terminal region, and these intra-molecular or inter-molecular interactions mask the binding sites of both the N-terminal and C-terminal domains resulting in an inactive state. Phosphorylation at a threonine residue in the C-terminal region disrupts the intra-molecular or intermolecular associations, resulting in an active state. These proteins have been implicated not only in cell-shape determination but also in signaling pathway. 7, 8) It is well known that hippocampal formation is involved in learning and memory, and it was reported that the hippocampus plays an important role in processing, and remembering spatial and contextual information. 9) Although ERM proteins have important implications in cell-shape determination and relevant signaling pathway, their association with visuo-spatial memory impairments in the hippocampus has not been reported yet. The purpose of the present study is to examine whether the expression level of ERM proteins in the hippocampus is changed by the intrastriatal injection of 6-OHDA in mice.
MATERIALS AND METHODS

6-OHDA-Microinjected Mice
Male C57BL/6N mice, weighting 18-23 g, were used in the present study. Mice were acclimated to and maintained at 23°C under a 12 h light/dark cycle (light on from 08:00 to 20:00 h). All animal experiments were carried out in accordance with 'the National Institutes of Health Guide for the Care and Use of Laboratory Animals,' and the protocols were approved by 'the Committee for Animal Research at Ritsumeikan University.' For stereotaxic microinjection, mice were anesthetized (sodium pentobarbital, 50 mg/kg, intraperitoneally (i.p.)) and immobilized in a Kopf stereotaxic frame. Subsequently, mice were microinjected with 6-OHDA (10 mg, Sigma, U.S.A.) in a final volume of 2 ml of sterilized physiological saline containing 0.02% ascorbic acid. As vehicle controls, sterilized physiological saline containing 0.02% ascorbic acid was microinjected. The intrastriatal injection coordinates (0.7 mm anterior-posterior, 0.8 mm left lateral, 2.7 mm ventral from the bregma) were according to a mouse brain atlas. Microinjection was administered by a motor-driven 10-ml Hamilton syringe using a 26-gauge needle. The infusion rate was 1 ml/min, and the injection cannula was kept in place for 5 min after the microinjection.
Water Maze Testing MWM examination was performed at 6 and 18 weeks after the instrastriatal injection of 6-OHDA. A circular pool (diameter, 100 cm; height, 50 cm) was filled with water (maintained at 25.0Ϯ1.0°C) and located in a large room with various distal visual cues. An invisible circular platform (diameter, 10 cm) was submerged approximately 1.0 cm below the surface of the water. For each daily block of three trials, mice were placed in the pool by hand facing the wall. Mice started a trial once from each of four randomized start locations. Mice were given a maximum of 60 s to find the platform. If a mouse failed to find the platform after 60 s, it was led there by the experimenter. All mice were allowed to remain on the platform for 30 s before being placed in a 37°C warming cage between trials. The intertrial interval (iti) was 4 min. After 24 h following the hidden platform testing, a probe trial was given by removing the platform from the tank and allowing the mice to search for 60 s. Swimming activity of each mouse was monitored via overhead mounted video, which relayed information including latency to find the platform, total distance traveled, and time and distance spent in each quadrant to a video tracking system (SMART, Bio Research Center, Japan). Probe trials were analyzed for both latency to first platform crossing and the total number of platform crossings.
Tissue Preparation and Immunohistochemistry At 6 weeks after the instrastriatal injection of 6-OHDA, brain slices were prepared for immunohistochemical analyses as described previously. 10) Brain slices were incubated with primary antibodies: mouse monoclonal antibodies against tyrosine hydroxylase (TH; diluted 1 : 10000, Sigma, St. Louis, MO, U.S.A.), microtubule-associated protein 2 (MAP2; 1 : 3000, Chemicon, Temecula, CA, U.S.A.) and neuronal nuclei (NeuN; 1 : 5000, Chemicon) for 3 d at 4°C. After several washes, these slices were incubated with biotinylated antibodies against mouse immunoglobulin G (IgG) (1 : 2000; Vector Laboratories, Burlingame, CA, U.S.A.) as appropriate for 2 h at room temperature. These slices were then incubated with avidin peroxidase (Vectastatin ABC Elite kit, 1 : 4000; Vector Laboratories) for 1 h at room temperature. All of slices were washed several times with phosphate buffered saline (PBS)-T between each incubation, and labeling was then revealed by 3,3Ј-diaminobenzidine (DAB; Dojindo Laboratories, Kumamoto, Japan), with nickel ammonium, which yielded a dark blue color.
Immunoblotting After water maze testing (at 19 weeks after the instrastriatal injection of 6-OHDA), hippocampus and cerebral cortex were rapidly removed and were prepared for neurochemical analyses as described previously.
11)
Aliquots containing 10 mg of protein were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then immunoblotting using mouse monoclonal antibodies to moesin (diluted 1 : 10, Sanko Junyaku Co., Ltd., Japan), radixin (1 : 10, Sanko Junyaku Co., Ltd.), and rabbit polyclonal antibodies to ezrin (1 : 1000, Cell Signaling Technology, U.S.A.), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1 : 1000, Cell Signaling Technology), respectively. Densitometric analysis was performed using the public-domain NIH Image 1.56 program.
HPLC Analysis DA and 3,4-dihydroxyindoleacetic acid (DOPAC) contents were measured using HPLC-ECD system. After water maze testing (at 19 weeks after the instrastriatal injection of 6-OHDA), the brain was removed and dissected on an ice-cold plate, and regions of the striatum were frozen. Each striatum tissue sample was homogenized in 0.1 N perchloric acid containing 50 mg/l ethylenediaminetetraacetic acid (EDTA) and 3,4-dihydroxybenzylamine hydrobromide (DHBA) as an internal standard. The homogenate was centrifuged at 15000ϫg for 15 min at 4°C and the supernatant was filtered through a 0.2-mm membrane filter. Then aliquots were directly analyzed for the levels of DA and DOPAC.
Statistical Evaluation All data are given as meanϮstan-dard error of mean (S.E.M.). In the Densitometric and HPLC analyses, the significance of differences was determined by Student's t-test. In the probe test and MWM, the statistical significance of differences was determined by one-way and two-way repeated measured analysis of variance (ANOVA), respectively. Further statistical analysis for multiple comparisons post-hoc test was carried out using Fisher least significant difference (LSD) method and Holm-Sidak method in the probe test and MWM, respectively.
RESULTS
Effects of 6-OHDA Lesion of the Striatum on Spatial
Discrimination in MWM At 6 weeks after the microinjection, we performed water maze testing using two experimental groups, 6-OHDA-microinjected mice (nϭ6) and vehiclemicroinjected mice (nϭ9) (Fig. 1) . In the acquisition trials, no difference was found in swimming speed (F 1,13 ϭ0.202, pϭ0.976) (Fig. 1B) . In the escape latency in the acquisition trials, the performance of 6-OHDA-microinjected mice in the water maze was significantly impaired (F 1,13 ϭ21.399, pϽ 0.001) (Figs. 1A, C) . Post-hoc analysis revealed this difference was primarily due to significant reduction in latencies to the platform in vehicle-microinjected mice during last 4 d of training. A probe trial given 24 h following training indicated a significant quadrant preference in vehicle-microinjected mice (F 1,3 ϭ26.177, pϽ0.001 ), but not 6-OHDA-microinjected mice (F 1,3 ϭ0.367, pϭ0.777) (Figs. 1D, E) .
At 18 weeks after the microinjection, we also performed a water maze testing. In the acquisition trials, the swimming speed was significantly different between vehicle-microinjected mice and 6-OHDA-microinjected mice (F 1,13 ϭ21.992, pϽ0.001) (Fig. 2B) . In the escape latency in the acquisition trials, the performance of 6-OHDA-microinjected mice was significantly impaired (F 1,13 ϭ38.168, pϽ0.001) (Figs.  2A, C) . A probe trial indicated a significant quadrant preference in vehicle-microinjected mice (F 1,3 ϭ3.744, pϭ0.033), but not 6-OHDA-microinjected mice (F 1,3 ϭ0.602, pϭ0.602) (Figs. 2D, E) .
Effects of Intrastriatal Injection of 6-OHDA on the Nigrostriatal DA System and Hippocampal Formation To evaluate the extent of DA neurodegeneration, we assessed immunoreactivity for TH in the striatum and the substantia nigra at 6 weeks after the microinjection (Fig. 3A) . In 6-OHDA-microinjected mice, TH immunoreactivity was reduced in both striatum and substantia nigra (Fig. 3A) . After the final water maze testing (at 19 weeks after the microinjection), we also analyzed striatal levels of DA and its major intra-neuronal degradation product, DOPAC by an HPLC-ECD system to confirm DA neurodegeneration. (Figs. 3D, E) . The microinjection of 6-OHDA reduced the striatal DA and the DOPAC contents by approximately 70%.
We further performed an immunohistochemical analysis in the hippocampus using anti-MAP2 and anti-NeuN antibodies, a major component of neuronal cytoskeletal protein and a marker of neuronal nuclei, respectively. In 6-OHDA-injected mice, MAP2 immunoreactivity of CA1 subfield in the hippocampus modestly reduced (Fig. 3B) . On the other hand, there was no difference in NeuN immunoreactivity between vehicle-injected mice and 6-OHDA-injected mice (Fig. 3C) .
Effects of Intrastriatal Injection of 6-OHDA on Hippocampal ERM Proteins We measured the optic densities of protein band of ezrin, radixin and moesin in each immunoblotting membrane, to determine the changes in protein-expressing levels in the hippocampus and cerebral cortex (Fig. 4) . Each band of ERM proteins was detected in the hippocampus and the cerebral cortex (Figs. 4A, B) . The level of ezrin in the hippocampus was increased to 220% in 6-OHDA-microinjected mice in comparison with that in vehi- cle-microinjected mice (Fig. 4C) , although the levels of other ERM proteins, moesin and radixin, were unaffected by intrastriatal injection of 6-OHDA (Fig. 4C) . There was no difference in levels of ERM proteins in the cerebral cortex between vehicle-injected mice and 6-OHDA-injected mice (Fig. 4D) .
DISCUSSION
In the present study, we showed that the intrastriatal injection of 6-OHDA induced partial dopaminergic deficits and spatial memory impairments. Cognitive abnormalities have been reported even at the early stage of PD when the degeneration of DA neurons is restricted to the striatal projections. 1, 2) Previous studies showed that DA innervation of the hippocampus arose from the ventral tegmantal area (VTA) as well as the substantia nigra pars compacta (SNpc). 12, 13) Also, direct projections from the CA1 subfield of the hippocampus and subiculum project primarily to the ventral striatum. [14] [15] [16] These results suggest that there may be some possible functional links between the hippocampal formation and the striatum, and some relationships between abnormalities of cognitive function in the hippocampus and the damage of dopaminergic neuronal network in nigrostriatal DA system. On the other hand, Parkinsonian signs appear when dopaminergic neural death exceeds a critical threshold: 70-80% of striatal nerve terminals and 50-60% of substantia nigra. 17) Previous studies reported that, in rodent models of PD, a loss of over 90% of TH activity and/or the amount of DA in the unilateral striatum caused drug-induced rotational asymmetry, 18, 19) and we have also obtained similar results. 20, 21) Thus, about 10% of the naïve striatal value may be a threshold level for TH activity and the amount of DA for behavioral changes. At the neurochemical level, the reduction in striatal DA levels found in the present study (approximately 70% in the whole striatum in Fig. 3D, E) was comparable to that de- and DOPAC (E) in the striatum from treated mice were measured using an HPLC-ECD system. Data are given as the meanϮS.E.M. (%) of five mice, with the density or amount of vehicle-treated control mice considered to be 100%. Significance: * pϽ0.05. Abbreviations: CPu, caudate putamen; SNpc, substantia nigra pars compacta; SNpr, substantia nigra pars reticulata. scribed by others. 22, 23) In MWM test, the swimming speed was significantly different between vehicle-microinjected mice and 6-OHDA-microinjected mice at 18 weeks after microinjection. The performance may be influenced by nonmotor functions including psychiatric symptoms. At least, spatial memory functions were decreased even at 18 weeks after the microinjection. Therefore, in the present study, the intrastriatal injection of 6-OHDA may lead to moderate abnormalities of cognitive function in the hippocampus and neurodegeneration in nigrostriatal DA system of C57BL/6N mice, similar to early stage of PD neuropathological episodes.
Morphological changes in neurons (dendritic length, and size, shape, and number of synapses) are hallmarks of longterm memory. 24) Actin filaments are intimately involved in neural morphology, and their regulation can influence memory. 25) In the present study, in 6-OHDA-injected mice, MAP2 immunoreactivity of CA1 subfield in the hippocampus modestly reduced (Fig. 3B) . We also found that ezrin level in the hippocampus was increased in 6-OHDA-microinjected mice. On the contrary, other ERM proteins, radixin and moesin were not influenced by 6-OHDA lesions. ERM proteins exist in the cytosol in an inactive state. Upon activation, they undergo a conformational change allowing them to bind with both plasma membrane proteins and actin filaments of the cytoskeleton, resulting in a physical and signal transduction link between the plasma membrane and cytoskeleton. 26, 27) Previous study suggested that the excessive activated ERM proteins caused a gain-of-function that perturbs the homeostasis of ERM proteins and actin filaments in sprouting neurites critical for neuronal morphogenesis. 28) On the other hand, small interference RNA-mediated knockdown of ERM proteins decreased filopodia density. 29) In pathological condition induced by intrastriatal microinjection of 6-OHDA, excessive expression of ezrin may be related to abnormalities of neuronal networks in the hippocampus and the resulting abnormalities of neuronal networks may contribute to visuospatial memory impairments. However, it remains to determine how expression of ezrin is increased by the intrastriatal injection of 6-OHDA. Further study is necessary to resolve the mechanism of excessive expression of ezrin in detail.
In conclusion, we demonstrated that the intrastriatal injection of 6-OHDA induced spatial memory impairments and partial dopaminergic deficits. We also found that the protein level of ezrin was increased approximately 2.2-fold by the intrastriatal injection of 6-OHDA, whereas expression levels of other ERM proteins, radixin and moesin, were unaffected by 6-OHDA lesions. These results suggest that an optimal amount of ERM proteins may be required for normal cognitive functions and that excessive ezrin may be related to cognitive dysfunction in pathological condition of PD. 
